Produktinformation
- 4-[[[[(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)amino]carbonyl]amino]sulfonyl]benzoic acidS 2574
Carboxy Gliclazide is a drug that belongs to the group of biguanides. It is used for the treatment of diabetes mellitus type 2. Carboxy Gliclazide binds to the endoplasmic reticulum and inhibits the oxidative activity, leading to improved insulin sensitivity. Carboxy Gliclazide also inhibits glucose production by pancreatic cells and reduces blood sugar levels in people with diabetes mellitus type 2. This medication can be taken as a tablet or an injection.